Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
NCT04986657

Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS

Led by Washington University School of Medicine · Updated on 2025-10-16

325

Participants Needed

1

Research Sites

328 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a single institution, prospective study of the whole genome sequencing assay, ChromoSeq. Using prospectively collected patient data, coupled with physician surveys, the investigators seek to determine the feasibility of implementing ChromoSeq in addition to standard genomic testing, for patients with the diagnoses of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).

CONDITIONS

Official Title

Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient with a clinical suspicion for a new diagnosis of AML or MDS for whom diagnostic molecular testing is requested or planned
  • Adult patients 18 years or older
  • Ability to understand and willing to sign an IRB approved informed consent document
  • Treating physician at Washington University School of Medicine directing therapy for hematologic malignancies
  • Physician able and willing to complete questionnaires about ChromoSeq usability and perceptions during implementation
Not Eligible

You will not qualify if you...

  • Younger than 18 years
  • Physician does not treat patients at Washington University School of Medicine

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Washington University School of Medicine

St Louis, Missouri, United States, 63110

Actively Recruiting

Loading map...

Research Team

M

Meagan Jacoby, M.D., Ph.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS | DecenTrialz